Gallup has scrapped its presidential approval tracking polls for good just as President Trump hits rock bottom in its numbers. The venerable public opinion firm announced Wednesday that it would no ...

On Thursday, Rasmussen’s daily tracker showed the president at 41 percent approval and 57 percent disapproval. On Wednesday, the president's approval rating was 43 percent, down from 44 percent the ...

The partial government shutdown brought on by concern over federal immigration enforcement ended Jan. 3 after President Donald Trump signed legislation passed by the House of Representatives. It's ...

Texas has so many massive AI-related data centers in development that its grid operator is now considering reevaluating some projects that were previously approved. The Electric Reliability Council of ...

President Donald Trump just hit a new low on one of the top issues he promised to fix. A new Reuters/Ipsos poll, released Monday, found Trump’s approval rating on his handling of immigration sank to ...

Presidential approval ratings offer a glimpse into how Americans really feel on any given day, often times driven by his handling of the issues at hand such as his recent Greenland news. Here's how ...

A new CNN poll finds 58% of respondents consider President Trump's first year back in office a failure. The poll shows Trump's overall approval rating at 39%, though he maintains strong support among ...

Recent polls show Donald Trump's approval rating ranging from 35% to 44%. Protests have occurred nationwide following the fatal shooting of a Minneapolis woman by an ICE officer. In South Carolina, ...

Recent polls show Donald Trump's approval rating ranging from 35% to 44%. Protests have occurred nationwide following the fatal shooting of a Minneapolis woman by an ICE officer. A December 2025 poll ...

President Donald Trump's approval ratings saw a slight uptick in most polls following a week marked by controversial events. In other international developments, Trump has also talked about taking ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...